Home › Funds › Science & Technology Partners, L.P. › WGS
Science & Technology Partners, L.P. position in WGS
GENEDX HOLDINGS CORP · Health Care
Science & Technology Partners, L.P. reported holding 335,435 shares of WGS (GENEDX HOLDINGS CORP) in its Q3 2026 13F filing — a position valued at US$24.3M, representing 4.10% of its reported portfolio and ranking #11 among its reported holdings. Science & Technology Partners, L.P. has disclosed WGS holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Science & Technology Partners, L.P.'s WGS position evolved
Science & Technology Partners, L.P. first disclosed a stake in WGS in Q4 2024 at 401,000 shares (US$30.8M). Across 8 filings, Science & Technology Partners, L.P. increased the stake 3 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 335,435 shares valued at US$24.3M — an increase of 229,048 shares quarter over quarter.. Notable position changes include a 31% trim in Q1 2025 (shares rose 4% over the following quarter), a 56% trim in Q2 2026 (shares rose 5% over the following quarter), a 215% increase in Q3 2026 (shares fell 28% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 401.00K | $30.82M | New |
| Q1 2025 | 276.64K | $24.50M | Reduce |
| Q2 2025 | 317.28K | $29.29M | Add |
| Q3 2025 | 224.07K | $24.14M | Reduce |
| Q4 2025 | 201.26K | $26.18M | Reduce |
| Q1 2026 | 241.20K | $15.49M | Add |
| Q2 2026 | 106.39K | $7.30M | Reduce |
| Q3 2026 | 335.44K | $24.25M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About WGS and 13F data
WGS (GENEDX HOLDINGS CORP) is a Health Care company. 29 other funds we track also report a position in WGS — the largest reported positions include Corvex Management (US$328.5M), Casdin Capital (US$254.5M), ARK Invest (US$138.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding WGS
- Corvex Management 4.78M sh · $328.46M · Q2 2026
- Casdin Capital 3.71M sh · $254.50M · Q2 2026
- ARK Invest 1.91M sh · $138.32M · Q3 2026
- Deep Track Capital, LP 1.20M sh · $86.76M · Q3 2026
- First Light Asset Management, LLC 783.92K sh · $53.82M · Q2 2026
- Amova Asset Management Americas, Inc. 661.81K sh · $47.80M · Q3 2026
- GAGNON SECURITIES LLC 516.28K sh · $37.33M · Q3 2026
- Zweig-DiMenna Associates LLC 358.10K sh · $25.89M · Q3 2026
More on Science & Technology Partners, L.P.
FAQ
How long has Science & Technology Partners, L.P. held WGS?
Science & Technology Partners, L.P. has disclosed WGS holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
What is Science & Technology Partners, L.P.'s current position in WGS?
As of Q3 2026, Science & Technology Partners, L.P. holds 335.44K shares of WGS (GENEDX HOLDINGS CORP), valued at $24.25M, representing 4.10% of its reported portfolio and ranking #11.
Has Science & Technology Partners, L.P. been buying or selling WGS?
In the latest 13F filing (Q3 2026), Science & Technology Partners, L.P. increased its position in WGS.
Which other funds hold WGS?
Other major institutional holders of WGS include Corvex Management, Casdin Capital, ARK Invest, among 29 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.